National Biomedical Research Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jun 24, 2021)
National Biomedical Research Act
This bill establishes and makes deposits through FY2031 into the Biomedical Innovation Fund for initiatives at the National Institutes of Health and the Food and Drug Administration. The fund supports (1) research for disease prevention, diagnosis, and treatment; (2) research for diseases that disproportionally account for federal health care spending; (3) the development, review, and post-market surveillance of medical products; and (4) other innovative medical research.
What just happenedJun 25, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJun 24, 2021
- Jun 25, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jun 24, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Rules, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Budget Committee - Jun 24, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Rules, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Rules Committee - Jun 24, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Rules, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jun 24, 2021IntroReferralIntro-H
Introduced in House
- Jun 24, 2021IntroReferral1000
Introduced in House